My research broadly aims to better understand the etiology of depression and risk behaviors such as suicide and substance use across development, and translate findings to inform prevention and intervention strategies for youth and families. My work focuses on partnering with communities and primary care clinics to improve access to and use of effective mental health services.
My current projects include studies focused on adapting and evaluating suicide prevention intervention and implementation strategies for use with adolescents and their families in primary care and outpatient medical settings, including developing and adapting brief, just-in-time, and digital interventions to expand access to services.
In addition to research, I am also a clinical psychologist in the Mood and Anxiety Disorders Program and the Crisis Care Clinic at Seattle Children’s Hospital.
I am a trained Behavioral Scientist with a PhD in Health & Human Performance. The main goal of my work is to reduce substance-related harms and improve quality of life for people experiencing problems related to their substance use. I work closely with community members who use drugs to inform my line of research and address key needs identified. My primary appointment is at the Harm Reduction Research and Treatment (HaRRT) Center within the UW School of Medicine and hold an Affiliate Faculty appointment within the School of Public Health. My aim is to adapt, refine, and disseminate harm reduction programs through digital health interventions to empower individuals and ameliorate substance-related harms.
Koriann Cox, Ph.D. graduated from Northeastern University and is licensed in the state of Washington. She completed a postdoctoral fellowship in co-occurring addiction and mental health and has a range of clinical experience with a variety of concerns including depression, anxiety, trauma, reproductive mental health, and substance and behavioral addictions. Dr. Cox’s strengths-focused approach emphasizes the mutual development of goals for therapy and ongoing collaboration between herself, the patient, and the care team. Dr. Cox uses a number of therapeutic modalities including but not limited to Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Cognitive Processing Therapy.
I am a counseling psychologist interested in developing and implementing culturally responsive, evidence-informed, family-centered, and non-pathologizing interventions. My practice and research are informed by postmodern ideas, especially narrative therapy. I provide clinical services at the Madison Clinic at Harborview Medical Center.
I am a behavioral neuroscientist who earned my PhD from Rutgers University and completed a postdoc here, in the Psychiatry and Behavioral Sciences Department at the University of Washington. My lab, located in the MIRECC at VA Puget Sound, aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making.
My primary focus is studying the neurobiological consequences and predictors of chronic fentanyl use. To accomplish this, I utilize cutting-edge in-vivo optical neuroscience tools (photometry, optogenetics, miniscopes) along with a newly developed oral-fentanyl self-administration model for rats and mice. I am also the lead developer for DeepSqueak, a popular software package for bioacoustics analysis that integrates machine-vision algorithms with an intuitive graphical interface to accelerate animal communication research.
Dr. Charles Engel is Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine, Core VA HSR Investigator in the Seattle Center for Innovation, Co-Director of the Center’s Advanced Fellowship on Health Systems Research, and Adjunct Physician Policy Researcher at the RAND Corporation. Engel’s work focuses on trauma-informed health systems and strategies for improving the quality of primary care for chronic mental and physical health conditions. His research has covered traumatic injury and post-trauma syndromes ranging from blast injury, mild traumatic brain injury and Gulf War syndrome to PTSD and depression. Engel is experienced at mixed qualitative and quantitative methods and has led large pragmatic randomized trials, program evaluations, and implementation science studies. He has authored or coauthored nearly 200 scholarly papers, including in the New England Journal of Medicine, JAMA, and the American Journal of Psychiatry. Funding for his work has come from the National Institutes of Health, Centers for Disease Control, Department of Veterans Affairs, Department of Defense and other organizations. Before joining UW Psychiatry and the AIMS Center in 2021, Dr. Engel was Senior Physician Policy Researcher at the RAND Corporation from 2013 to 2020 and Associate Chair (Research) at Uniformed Services University’s Department of Psychiatry from 2001-2013. Engel has served on the board of directors of the International Society for Traumatic Stress Studies, has testified twice before Congress, received a number of awards, and delivered invited lectures in over 10 countries. He received both his MD and MPH from the University of Washington.
I am a clinical psychologist and researcher. My research focuses on pediatric psychology, intervention science, and leveraging digital technologies to disseminate and implement evidence-based psychosocial interventions for children, teens, and young adults with serious medical conditions and co-occurring anxiety, stress, and depression. Digital mental health care initiatives have the potential to scale-up interventions and overcome structural barriers and unequal access to psychosocial care. Current and future research investigations aim to help improve patient and family coping skills, psychosocial well-being, and quality of life by developing and implementing evidence-based mental health interventions.
I am a child and adolescent psychiatrist at Seattle Children’s Hospital and faculty member at the University of Washington Medicine. My SCH practice locations include the Gender Clinic (Adolescent Medicine), Outpatient Psychiatry Clinic, Autism Center, and the inpatient unit- Psychiatry and Behavioral Medicine Unit (PBMU). I believe in delivering compassionate, evidence-based care in supporting patients and their families. My approach is both comprehensive and patient-centered, as it is important to consider the needs of the individual while also appreciating societal and cultural context. I specialize in working with diverse patient populations with various marginalized identities, such as those who identify as LGBTQ, gender diverse, and/or neurodiverse. I also work closely with the Adolescent Medicine Gender Clinic in supporting any mental health needs of transgender/gender diverse youth and their families. I also collaborate with colleagues in specialty medical clinics to coordinate care of medically complex patients. Additionally, I serve as a consultant with various school programs to support mental health initiatives and advocacy efforts.
Academically, I am involved with several initiatives both locally and nationally, particularly those that work to promote diversity and equity. I serve on committees supporting the SCH/UW CAP Fellowship Program, educating trainees and students through direct clinical supervision as well as with lectures and discussions. On a national level, I serve on the Sexual Orientation and Gender Identity Issues Committee (SOGIIC) for the American Academy of Child and Adolescent Psychiatry (AACAP). My clinical research focuses on finding strategies to better support the mental health and well-being of patients and families who are LGBTQ+. Additionally, I work on studies that explore the intersection between gender diversity and neuro diversity/autism spectrum.
